Down-Regulation of Survivin by Nemadipine-A Sensitizes Cancer Cells to TRAIL-Induced Apoptosis |
Park, Seong Ho
(Ilsong Institute for Life Science, Hallym University)
Park, So Jung (Graduate School of East-West Medical Science, Kyung Hee University) Kim, Joo-Oh (Graduate School of East-West Medical Science, Kyung Hee University) Shin, Ji Hyun (Graduate School of East-West Medical Science, Kyung Hee University) Kim, Eun Sung (Graduate School of East-West Medical Science, Kyung Hee University) Jo, Yoon Kyung (Graduate School of East-West Medical Science, Kyung Hee University) Kim, Jae-Sung (Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Science) Park, So Jung (Asan Institute for Life Science, Asan Medical Center) Jin, Dong-Hoon (Asan Institute for Life Science, Asan Medical Center) Hwang, Jung Jin (Asan Institute for Life Science, Asan Medical Center) Lee, Seung Jin (Asan Institute for Life Science, Asan Medical Center) Jeong, Seong-Yun (Asan Institute for Life Science, Asan Medical Center) Lee, Chaeyoung (Department of Bioinformatics and Life Science, Soongsil University) Kim, InKi (Asan Institute for Life Science, Asan Medical Center) Cho, Dong-Hyung (Graduate School of East-West Medical Science, Kyung Hee University) |
1 | Abdulghani, J. and El-Deiry, W. S. (2010) TRAIL receptor signaling and therapeutics. Expert Opin. Ther. Targets 14, 1091-1108. DOI ScienceOn |
2 | Altieri, D. C. (2010) Survivin and IAP proteins in cell-death mechanisms. Biochem. J. 430, 199-205. DOI ScienceOn |
3 | Ammann, J. U., Haag, C., Kasperczyk, H., Debatin, K. M. and Fulda, S. (2009) Sensitization of neuroblastoma cells for TRAIL-induced apoptosis by NF-kappaB inhibition. Int. J. Cancer 124, 1301-1311. DOI ScienceOn |
4 | Bellail, A. C., Qi, L., Mulligan, P., Chhabra, V. and Hao, C. (2009) TRAIL agonists on clinical trials for cancer therapy; the promises and the challenges. Rev. Recent Clin. Trials 4, 34-41. DOI ScienceOn |
5 | Cho, D. H., Jo, Y. K., Hwang, J. J., Lee, Y. M., Roh, S. A. and Kim, J. C. (2009) Caspase-mediated cleavage of ATG6/Beclin-1 links apoptosis to autophagy in HeLa cells. Cancer Lett. 274, 95-100. DOI ScienceOn |
6 | Frokjaer-Jensen, C., Kindt, K. S., Kerr, R. A., Suzuki, H., Melnik-Martinez, K., Gerstbreih, B., Driscol, M. and Schafer, W. R. (2006) Effects of voltage-gated calcium channel subunit genes on calcium influx in cultured C. elegans mechanosensory neurons. J. Neurobiol. 66, 1125-1139. DOI ScienceOn |
7 | Hanahan, D. and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70. DOI ScienceOn |
8 | Hou, W., Han, J., Lu, C., Goldstein, L. A. and Rabinowich, H. (2008) Enhancement of tumor-TRAIL susceptibility by modulation of autophagy. Autophagy 4, 940-943. DOI |
9 | Hui, K., Kwok, T. C., Kostelecki, W., Leen, J., Roy, P. J. and Feng, Z. P. (2009) Differential sensitivities of CaV1.2 IIS5-S6 mutants to 1,4-dihydropyridine analogs. Eur. J. Pharmacol. 602, 255-261. DOI ScienceOn |
10 | Jiang, C. C., Chen, L. H., Gillespie, S., Kiejda, K. A., Mhaidat, N., Wang, Y. F., Thorne, R., Zhang, X. D. and Hersey, P. (2007) Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response. Cancer Res. 67, 5880-5888. DOI ScienceOn |
11 | Jin, C. Y., Moon, D. O., Lee, J. D., Heo, M. S., Choi, Y. H., Lee, C. M., Park, Y. M. and Kim, G. Y. (2007) Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells. Carcinogenesis 28, 1058-1066. |
12 | Johnstone, R. W., Frew, A. J. and Smyth, M. J. (2008) The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat. Rev. Cancer 8, 782-798. DOI ScienceOn |
13 | Jouan-Lanhouet, S., Arshad, M. I., Piquet-Pellorce, C., Martin-Chouly, C., Le Moigne-Muller, G., Van Herreweghe, F., Takahashi, N., Sergent, O., Lagadic-Gossmann, D., Vandenabeele, P., Samson, M. and Dimanche-Boitrel, M. T. (2012) TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ. 19, 2003-2014. DOI ScienceOn |
14 | Kaddour-Djebbar, I., Lakshmikanthan, V., Shirley, R. B., Ma, Y., Lewis, R. W. and Kumar, M.V. (2006) Therapeutic advantage of combining calcium channel blockers and TRAIL in prostate cancer. Mol. Cancer Ther. 5, 1958-1966. DOI ScienceOn |
15 | Kim, Y. and Seol, D. W. (2003) TRAIL, a mighty apoptosis inducer. Mol. Cells 15, 283-293. |
16 | Kanwar, J. R., Kamalapuram, S. K. and Kanwar, R. K. (2011) Targeting survivin in cancer: the cell-signalling perspective. Drug Discov. Today 16, 485-494. DOI ScienceOn |
17 | Kawasaki, H., Toyoda, M., Shinohara, H., Okuda, J., Watanabe, I., Yamamoto, T., Tanaka, K., Tenjo, T. and Tanigawa, N. (2001) Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91, 2026-2032. DOI ScienceOn |
18 | Kim, I. K., Chung, C. W., Woo, H. N., Hong, G. S., Nagata, S. and Jung, Y. K. (2000) Reconstitution of caspase-8 sensitizes JB6 cells to TRAIL. Biochem. Biophys. Res. Commun. 277, 311-316. DOI ScienceOn |
19 | Kim, S., Kang, J., Qiao, J., Thomas, R. P., Evers, B. M. and Chung, D. H. (2004) Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas. J. Pediatr. Surg. 39, 516-521. DOI ScienceOn |
20 | Kwok, T. C., Ricker, N., Fraser, R., Chan, A. W., Burns, A., Stanley, E. F., McCourt, P., Cutler, S. R. and Roy, P. J. (2006) A small-molecule screen in C. elegans yields a new calcium channel antagonist. Nature 441, 91-95. DOI ScienceOn |
21 | Lamy, V., Bousserouel, S., Gosse, F., Minker, C., Lobstein, A. and Raul, F. (2011) Lupulone triggers p38 MAPK-controlled activation of p53 and of the TRAIL receptor apoptotic pathway in human colon cancer-derived metastatic cells. Oncol. Rep. 26, 109-114. |
22 | Li, S.S., Yang, S., Wang, S., Yang, X. M., Tang, Q. L. and Wang, S. H. (2011) Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway. Oncol. Rep. 26, 1573-1579. |
23 | Lu, M., Strohecker, A., Chen, F., Kwan, T., Bosman, J., Jordan, V. C. and Cryns, V. L. (2008) Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. Clin. Cancer Res. 14, 3168-3176. DOI ScienceOn |
24 | Mahalingam, D., Szegezdi, E., Keane, M., de Jong, S. and Samali A. (2009) TRAIL receptor signalling and modulation: Are we on the right TRAIL? Cancer Treat Rev. 35, 280-288. DOI ScienceOn |
25 | Oh, B., Park, S., Pak, J. H. and Kim, I. (2012) Downregulation of Mcl-1 by daunorubicin pretreatment reverses resistance of breast cancer cells to TNF-related apoptosis-inducing ligand. Biochem. Biophys. Res. Commun. 422, 42-47. DOI ScienceOn |
26 | Okamoto, K., Okamoto, I., Okamoto, W., Tanaka, K., Takezawa, K., Kuwata, K., Yamaguchi, H., Nishio, K. and Nakagawa, K. (2010) Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations. Cancer Res. 70, 10402-10410. DOI ScienceOn |
27 | Raviv, Z., Zilberberg, A., Cohen, S., Reischer-Pelech, D., Horrix, C., Berger, M. R., Rosin-Arbesfeld R. and Flescher E. (2011) Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity. Br. J. Pharmacol. 164, 1433-1444. DOI ScienceOn |
28 | Ortiz, J. and Chou, L. L. (2012) Calcium up-regulated survivin expression and associated osteogenesis of normal human osteoblasts. J. Biomed. Mater. Res. 100, 1770-1776. |
29 | Park, S. J., Park, S. H., Kim, J., Kim, J. H., Park, S. J., Hwang, J. J., Jin D.H., Jeong S., Lee S.J., Kim J.C., Kim I. and Cho D.H. (2012) Carnitine sensitizes TRAIL-resistant cancer cells to TRAIL-induced apoptotic cell death through the up-regulation of Bax. Biochem. Biophys. Res. Commun. 428, 185-190. DOI ScienceOn |
30 | Pennati, M., Colella, G., Folini, M., Citti, L., Daidone, M. G. and Zaffaroni, N. (2002) Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis. J. Clin. Invest. 109, 285-286. DOI |
31 | Ryan, B. M., O'Donovan, N. and Duffy, M. J. (2009) Survivin: a new target for anti-cancer therapy. Cancer Treat. Rev. 35, 553-562. DOI ScienceOn |
32 | Stout, R. F. Jr. and Parpura, V. (2011) Voltage-gated calcium channel types in cultured C. elegans CEPsh glial cells. Cell Calcium 50, 98-108. DOI ScienceOn |
33 | Sung, E. S., Kim, A., Park, J. S., Chung, J., Kwon, M. H. and Kim Y. S. (2010) Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells. Apoptosis 10, 1256-1269. |
34 | Sung, E. S., Park, K. J., Choi, H. J., Kim, C. H. and Kim, Y. S. (2012) The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells. Exp. Cell Res. 318, 1564-1576. DOI ScienceOn |
35 | Zhang, X., Inukai, T., Akahane, K., Hirose, K., Kuroda, I., Honna, H., Goi, K., Kagami, K., Tauchi, T., Yagita, H. and Sugita, K. (2011) Endoplasmic reticulum stress inducers, but not imatinib, sensitize Philadelphia chromosome-positive leukemia cells to TRAIL-mediated apoptosis. Leuk. Res. 35, 940-949. DOI ScienceOn |
36 | Tamm, I., Wang, Y., Sausville, E., Scudiero, D. A., Vigna, N., Oltersdorf, T. and Reed, J. C. (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58, 5315-5320. |
37 | Vader, G., Kauw, J. J., Medema, R. H. and Lens, S. M. (2006) Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody. EMBO Rep. 7, 85-92. DOI ScienceOn |
38 | van Geelen, C. M., Pennarun, B., Le, P.T., de Vries, E. G. and de Jong, S. (2011) Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5. BMC Cancer 11, 39. DOI ScienceOn |